Wegovy leads to weight loss. Can it treat depression, too?

ILLUSTRATION:CHRISTINEKAO/STAT;PHOTOS:ADOBEDrugslikeOzempicandWegovy—alreadygamechangersfordiabetesa AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs




explore

author：Wikipedia    Page View：6
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： Poor hospice wound care hurts patients and families
Next article： Hollywood unions extend contract negotiations for actors